Cinco, Mary Rose D.
HRN: 21-33-53 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/17/2022
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
05/17/2022
05/23/2022
PO
4ml
BID
PC TNTC
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes